CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Lupin

For profit

Also known as: Director, Clinical Operations | LPI | LUPIN | LUPIN ATLANTIS | Lupin Atlantis Holdings S.A. | Lupin Limited | LUPIN LIMITED | Lupin Limited (Biotech Division) | Lupin Ltd. | LUPIN LTD | Lupin Pharmaceuticals, Inc. | LUPIN PHARMS | Lupin Research Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2008

First marketed drug

Dec 14, 1987

Last known activity

Jun 2, 2026

Timeline

1960s

  1. Jan 1, 1968

    Lupin— Founded

2010s

  1. Jan 1, 2015

    Gavis Pharmaceuticals— Acquired

  2. Apr 10, 2015

    memantine— Marketing Organization

  3. Aug 4, 2017

    pitavastatin— NDA Secondary Org

  4. Oct 1, 2017

    Symbiomix Therapeutics— Acquired

Drugs by trial phase (14 distinct, 25 trials)

Phase 4 (1 own, 1 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (211)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (27)

Details

Founded
Rajasthan, IN Jan 1, 1968
Last known activity
Jun 2, 2026